Tian Chang Acquires RMB66.80 Million of Injection-Molding Equipment; Arranges RMB13.60 Million Sale-and-Leaseback Financing

Bulletin Express
Yesterday

Hong Kong – 7 October 2026 – Tian Chang Group Holdings Ltd. announced three discloseable transactions that expand its production capacity and optimise near-term liquidity.

Plastic injection line • Huizhou Tian Chang, an indirect subsidiary, ordered nine plastic injection-molding machines from Vendor A for RMB15.10 million (HK$17.60 million). • The subsidiary will fund 10% of the purchase up-front from internal resources, with the remaining 90% to be covered through a finance lease.

Sale-and-leaseback financing • Under a finance lease signed the same day, Ningbo Zhongjin will purchase the newly ordered plastic machines from Huizhou Tian Chang for RMB13.60 million (HK$15.90 million) and lease them back over 41 months. • Lease payments total RMB14.30 million (HK$16.70 million), implying a flat interest rate of 1.8% per annum. Payments start in month 6 following delivery, preceded by a five-month rent-free period. Ownership reverts to Huizhou Tian Chang for RMB1 at lease expiry.

Magnesium thixomolding expansion • Tian Hao, another indirect subsidiary, placed two orders with Vendor B for nine magnesium injection-molding machines: – Eight units for RMB34.90 million (HK$40.90 million); 20% deposit due within 14 days and balance within six months of installation. – One unit for RMB16.80 million (HK$19.70 million); 10% deposit on signing and balance within three months of commissioning. • Combined consideration for the magnesium equipment totals RMB51.70 million (HK$60.50 million), fully funded by internal resources.

Strategic rationale Management expects the plastic machinery to support a new integrated plastic solutions line, while the magnesium thixomolding equipment broadens the group’s advanced materials capability. The sale-and-leaseback structure is intended to conserve cash for ongoing operations.

Regulatory classification Each transaction, as well as their respective aggregates with earlier deals, exceeds the 5% but remains below the 25% listing-rule threshold; therefore all are treated as discloseable transactions requiring announcement but not shareholder approval.

Currency translation in this release follows the company’s illustrative rate of RMB1 = HK$1.170.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10